Keywords: b-ms, starts, vanlev, trial, ish, bristol-myers, squibb

B-MS starts Vanlev trial in ISH

Article | 28 January 2000

Bristol-Myers Squibb has begun a clinical trial of its novelanthypertensive agent Vanlev (omapatrilat), a vasopeptidase inhibitor, in the management of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Bristol-Myers Squibb

Go to company listing